SUMMARY The effect of intracoronary nifedipine on regional and global left ventricular performance, coronary vasomotility, and myocardial oxygen consumption is reported. Left ventricular pressures and volume indices of contractility and relaxation were simultaneously recorded in five patients without coronary artery disease. In these patients, nifedipine in the left main coronary artery not only delayed (+115 ms) anterior wall contraction but also slowed (3-5 vs 1*9 cm/s) and depressed it (-26%), resulting in a depression of global left ventricular ejection. This asynchrony and depression of regional contraction is considered to be responsible for the slowed isovolumic contraction and relaxation of the whole ventricle. In 10 other patients with coronary artery disease, coronary sinus blood flow and myocardial oxygen consumption were measured before and after intracoronary nifedipine. The observed decrease in myocardial oxygen consumption (-28%) depended primarily on a decrease in contractility and left ventricular performance. In a third study group of 12 patients with coronary artery disease, the effects of intracoronary nifedipine on the coronary vasomotility of 40 coronary segments (normal, prestenotic, stenotic, poststenotic) were quantitatively determined. Left ventricular haemodynamics and coronary sinus saturation were monitored while the cineangiograms were recorded before and after nifedipine. Nifedipine provoked vasodilatation of the normal (+ 10.3%), prestenotic, stenotic (+4 to 300/%), and poststenotic (+ 16.4%) coronary segments, which persisted after the disappearance of its direct effects on the myocardium. This transient regional "cardioplegic " effect of nifedipine, associated with an increase in coronary blood flow, a reduction in myocardial oxygen consumption, and a vasodilatation of the epicardial vessels is likely to be beneficial during temporary coronary occlusion such as occurs in spasm or transluminal angioplasty. 
Direct intracoronary injection of nifedipine is used increasingly in an effort to reverse spontaneously occurring or induced spasml 2 and to restore coronary blood flow. Recently introduced techniques, such as transluminal angioplasty and fibrinolytic recanalisation of coronary artery thrombosis have also become indications34 for injecting nifedipine directly into the affected coronary artery, since it is argued that the specific inhibitory action of nifedipine on contractile energy expenditure may favourably influence the Part of this work has been presented at the 53rd and 54th Scientific Sessions of the American Heart Association.
Accepted for publication 9 For the first part of the study, five patients (32 to 55 years) were catheterised because of suspected coronary artery disease. Four had atypical chest pain and Semruys, Hooghoudt, Reiber, Slager, Brower, Hugenholtz one had exertional angina, but all proved to have normal coronary arteries, with ejection fractions well within the normal range. One patient, however, had asymmetrical septal hypertrophy without outflow obstruction and one had electrocardiographic evidence of left ventricular hypertrophy without strain.
Pressures were recorded with a tip-manometer mounted on an 8 F catheter*. Derived variables were calculated on line by a computer system.5 A 300 right anterior oblique ventriculogram (50 frames per second) was obtained by injection of 0 75 ml/kg 76% Urografint. When diagnostic coronary arteriography showed normal coronary arteries, informed consent was obtained for the remainder of the study. This included an additional left ventricular cineangiogram 30 seconds after a bolus injection of 0*075 to 0*175 mg nifedipine into the left main coronary artery. The injection was made no sooner than 20 minutes and only after left ventricular end-diastolic pressure and the contractility variables were identical with those recorded before the initial angiogram.
The patient's position was kept unchanged in relation to the x-ray equipment during both angiograms. Movement of the diaphragm was excluded by shallow inspiration, taking care to prevent the Valsalva manoeuvre.
ANALYSIS OF ISOVOLUMIC INDICES DURING VENTRICULOGRAPHY
The on-line computer system provides the following data: peak left ventricular pressure (mmHg), left ventricular end-diastolic pressure (mmHg), and peak positive rate of change of pressure (pk+dP/dt in mmHg/s). In addition, isovolumic relaxation phase variables were calculated: peak negative rate of change of pressure (pk-dP/dt) and the time constant of relaxation (T) by the least squares fit of P=eAt'+B (T= -1/A) from the moment of pk-dP/dt to the opening of the mitral valve. 6 The opening of the mitral valve was defined from the angiographic frame preceding that in which non-opacified blood first entered the left ventricle. In all cases mitral valve opening was identified in the same frame by two End-systole was defined at the occurrence of the incisura of the central aortic pressure, recorded with a tip-manometer on a SF catheter*. Early diastole was defined as the interval between the opening of the mitral valve and minimal ventricular diastolic pressure. Early diastolic left ventricular inflow volume was measured as an absolute value (ml), and early diastolic mean inflow rate was calculated as the ratio between the difference of ventricular volumes at minimal pressure and opening of the mitral valve and the time interval corresponding to the number of frames between them.
To analyse regional left ventricular function, a system of 20 co-ordinates is generated7 along which the left ventricular displacement is determined frame by frame (Fig. 1) .
The orientation of the 20 co-ordinate axes was originally developed from the motion of these endocardial sites in normal subjects7 and formulated in a generalised mathematical expression amenable to automatic data processing.
Regional wall velocity was computed as the first derivative of the instantaneous displacement function. Mean wall velocity (V) was calculated from enddiastole to end-systole (Fig. 1) .
To express quantitatively the contribution of a particular segment to global ejection fraction, segmental volume was computed from the local radius and the height of each segment and indexed for end-diastolic volume (Fig. 2) . This was termed regional contribution to global ejection fraction. The sum of all 20 determinations equals the global ejection fraction. Diastolic pressure-volume relations were determined from the minimal diastolic pressure to the beginning of the "a" wave. The natural logarithm of pressure was used in a linear regression analysis of pressure and volume from which a slope k was derived. Changes in k were taken as changes in volume stiffness.8
CORONARY SINUS BLOOD FLOW MEASUREMENT AND MYOCARDIAL OXYGEN CONSUMPTION
In the second part of this study, the effect of intracoronary injection of nifedipine on coronary sinus blood flow and myocardial oxygen consumption was determined in 10 other patients (54 to 68 years), who all had significant coronary heart disease.
Blood flow was measured via the continuous ther- (mmHg) (mmHgls) Figure: after nifedipine an overall depression of regional pump function is observed which is more pronounced in the anterior (segments 1-8) and apical (9, 10, 19, 20) areas.
are shown in Table la (Fig. 4) . It is evident that the entire diastolic pressure-volume relation is shifted so that, at any given volume, pressure is higher. This effect was consistently seen after each administration of nifedipine. The slope of the LnP vs volume line, however, (KY-an index of volume stiffness-was considerably reduced in all patients.
REGIONAL LEFT VENTRICULAR FUNCTION
The profound effect of intracoronary nifedipine on left ventricular wall motion and its time sequence is shown in Fig. 5 . Before administration of nifedipine, displacement of the anterior and inferior wall was seen, 29 and 28 ms, respectively, after end-diastole (Table 2 ). After injection of nifedipine into the main stem of the left coronary artery, the onset of displacement of the anterior wall was delayed an additional 115 ms (p<0.001), while the inferior wall was delayed by 44 ms (p<0-001). For each segment the timing relation between aortic valve closure and the occurrence of the maximal wall displacement is shown in Fig. 6 . Before nifedipine, the maximal displacement of the anterior wall occurred 11 ms before aortic valve closure. In contrast, with the anterior wall segments, the inferoposterior wall segments did not reach their maximal wall displacement synchronously. The maximal displacement of the five posterobasal segments (no. 11-15) occurred between 20 and 100 ms after aortic valve closure so that the maximal wall displacement of the entire inferior wall fell, on average, 10 ms after aortic valve closure. After nifedipine, the moment of maximal wall displacement for the anterior wall shifted from end-systole (11 ms before aortic valve closure) to early diastole (60 ms after aortic valve closure). The anterolateral and the apical segment of the anterior wall, as well as the apical segment of the inferior wall appear to be the most affected. On the contrary, the posterobasal wall segments reach their maximum in end-systole, instead of early diastole.
The measurement of mean systolic wall velocity after nifedipine showed a decrease which was again more pronounced in the anterior wall ( 6 .0 to 11-9 mlV100 ml; p<0.0001), and this was reflected in a considerable narrowing of the aortic-coronary sinus oxygen difference (from 12-7 to 6.3 ml100 ml; p<0-0001). In this group of patients, the net increase in myocardial blood flow was smaller than expected from the narrowing of the aortic-coronary sinus oxygen difference, reflecting a reduced myocardial oxygen consumption (from 13.4 to 9.6 ml!min; p<001).
QUANTITATIVE CORONARY CINEANGIOGRAPHY
Haemodynamic data assessing the effects of nifedipine on the epicardial coronary arteries are shown in Table 4 Table 5 and shown in Fig. 8 . One of the 17 poststenotic segments was excluded from the statistical analysis because it showed a paradoxical reduction of 600/o in diameter after nifedipine. There is no significant difference in the mean diameter between the first and the second control cinefilm. After administration of nifedipine (film N2), all segments (N=29) showed an increase of 12% (p<0-0001) in mean diameter, except for three coronary segments (one prestenotic, two poststenotic in series in the same artery).
These changes in detail were as follows. dilated with nifedipine and their luminal diameters increased in absolute terms over a range of 4 to 300/o (Table 6 ). There was a slight reduction in diameter in one segment. It is clear that the normal, prestenotic, stenotic, and poststenotic segments remained in a state of vasodilatation even when Vmax and the coronary sinus saturation had returned to their control values. In other words, nifedipine provokes a coronary vasodilatation which persists after the disappearance of its direct effects on the myocardium. Inflence of intracoronaty nifedipine opening the majority of the anterior and inferoapical segments show a persisting inward wall motion, in contrast with the inferobasal segments which move outward. Column D2 (displacement 2) expresses the net effect of inward and outward wall displacement as computed just before mitral valve opening.
From the displacement D, and D2 the segmental volume displacements are computed. The total volume displaced between end-diastole and aortic valve opening equals that displaced between end-diastole and mitral valve opening. Thus, the ventricular volume remains constant while a variety of segmental wall motion changes takes place. In studying this illustration it becomes obvious that changes in the rate of pressure relaxation may not only reflect a globally altered myocardial relaxation but also heterogeneity in activation and performance within the sarcomere population, with continuation of contraction and tension development extending into the isovolumic period. In other words, impaired relaxation of the ventricle as a whole must not automatically be equated with impaired relaxation at a cellular level.
Fleckenstein et al. 7 have indicated that electromechanical decoupling occurs after nifedipine which leads to a decrease in actin-myosin interaction. The negative inotropic effect on the heart which was recorded and the upward shift in left ventricular diastolic pressure volume curves observed in this study are probably an expression of that fundamental biochemical effect: nifedipine interrupts the normal process by which calcium is transported to the cell, lowers the cytosolic calcium, and inhibits and delays contraction of the myocardial wall so that there is delay in diastolic interaction of contractile elements. This could be a reasonable explanation for the upward shift in left ventricular diastolic pressure volume curves. On the other hand, residual diastolic interaction between contractile elements-caused by an increased cytosolic calcium18-has also been proposed as a possible explanation for the upward shift in diastolic pressure volume relations seen during angina. 19 In our patients the myocardial oxygen consumption decreased by 280/o after intracoronary injection of nifedipine. From our haemodynamic and angiographic data we assume that the decrease in myocardial oxygen consumption depended primarily on a decrease in contractility and left ventricular performance. This interpretation, however, is open to question, since despite an increase in global coronary blood flow, a decrease in endocardial flow and oxygen supply could make the endocardium ischaemic and consequently alter its mechanical performance. Others have pointed to the fact that after administration of a coronary vasodilator endocardial capillary blood flow may actually decrease because of an epicardial coronary "steal" phenomenon. 22 This difference in regional blood flow response is seen particularly when coronary blood flow is increased in the presence of a critical stenosis of a large coronary artery.2324 In these circumstances, when flow is increased as a result of arteriolar dilatation distal to the stenosis, transmural perfusion becomes heterogeneous because of the greater increase in epicardial flow. 25 In the present study we do not have any experimental evidence which would allow us to rule out this possibility, but Henry et al. 26 have shown that, in dogs subjected to coronary occlusion, nifedipine increases collateral flow to the ischaemic myocardium. This increase was accompanied by a relative increase in endocardial perfusion, a phenomenon that was particularly prominent in the ischaemic zone.26 QUANTITATIVE The present study provides quantitative measurements of the effects of nifedipine on the epicardial coronary artery after direct intracoronary administration. This route of administration was used in order to dissociate its coronary vasodilator action from its direct myocardial effect and afterload reduction. '2 28 When nifedipine (0O 1 mg) was intravenously injected, it had no detectable haemodynamic effects. When nifedipine was regionally administered, it had a transient negative inotropic effect, associated with a transient increase in coronary blood flow and decrease in myocardial oxygen consumption. The vasodilatation of all three, the prestenotic, stenotic, and poststenotic coronary segments, persisted, however, much longer than the haemodynamic effects, at least during the period of observation in this study. This observation raises the possibility that there are distinct differences in the response to nifedipine between the myocardial cells and the smooth muscle cells in the coronary vascular wall.
Another essential question is: what effect do large vessel vasomotor tone and distal arteriolar resistance have on a proximal lesion? In isolated perfused human coronary arteries, a decrease in perfusion pressure can lead to a "dynamic" increase in resistance to flow across an elastic and eccentric stenosis. 29 The study has even shown experimentally that the administration of a coronary vasodilator could induce a fall into distending pressure of the poststenotic coronary segment, resulting in a passive collapse of the wall of the stenotic segment and an increase in resistance to flow. [30] [31] [32] An explanation for these conflicting possibilities may be that in the experimental studies the vasodilators affected primarily the distal arteriolar coronary bed leading to a reduction in poststenotic intraluminal pressure, whereas in the clinical studies the epicardial large coronary arteries were primarily affected in their prestenotic as well as in their poststenotic segment.33
Conclusion
Intracoronary nifedipine not only delays and prolongs the segmental contraction, but also slows and depresses it. It is suggested that a decreased cytosolic calcium might induce delayed diastolic interaction between contractile elements which could be a reasonable explanation for alteration of the isovolumic relaxation and for the upward shift in the left ventricular pressure volume curve after intracoronary administration of nifedipine. We presume that the decrease .in myocardial oxygen consumption depends primarily on a decrease in contractility and left ventricular performance. Finally, we showed that the vasodilatation of the epicardial vessels after intracoronary nifedipine persists longer than its direct effects on the myocardium. In conclusion, the transient regional "cardioplegic" effect of nifedipine, associated with an increase in coronary blood flow, a reduction in MVO2, and a vasodilatation of the epicardial vessels, is likely to be beneficial during temporary coronary occlusion. We acknowledge the technical assistance given by Johan C H Schuurbiers and Inge C J Zorn. 
